reviews on glp-1 patches Patches: Do They Work? Do GLP-1 Patches Work for

2018;25(11271134) doi: 10.1016/j.celrep.2018.10.018

[DOI] [PMC free article] [PubMed] [Google Scholar] 49.Apostolova N., Vezza T., Muntane J., Rocha M., Vctor V.M

FDA may issue no objection (the company may market, though this is not approval) or object (e.g., safety concerns or incomplete data)

These trials must be designed with primary ophthalmic endpoints, such as slowing the rate of RGC loss or preserving visual field, to definitively establish a disease-modifying effect

Another study found that GLP-1 agonists are associated with a lower risk of major adverse kidney events and death from cardiovascular causes in people with type 2 diabetes and chronic kidney disease

ARB=angiotensin receptor blocker